International Clinical Trial: Prospective, Single-Center, Single-Arm Exploratory Clinical Study of iparomlimab and tuvonralimab Combined with Platinum-Containing Chemotherapy and Cetuximab in First-Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127041) titled 'Prospective, Single-Center, Single-Arm Exploratory Clinical Study of iparomlimab and tuvonralimab Combined with Platinum-Containing Chemotherapy and Cetuximab in First-Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma' on June 23.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Guangxi Medical University Cancer Hospital

Condition: Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Without Indication for Local Curative Treatment

Recruitment Status: Not Recruiting

Phase: 0

Date of First Enrollment: 2026-07-15

Target Sample Size: test group:3...